DALLAS - TelAve -- A Cure In Sight (ACIS), in collaboration with UT Southwestern Medical Center, brought patients, caregivers, physicians, researchers, and advocates together for the 2026 Eye Believe Survivorship Seminar in Dallas. Held October 2–3, the event combined ocular melanoma education with practical support and opportunities to connect with others navigating the disease.

Hosted with J. William "Bill" Harbour, MD, Professor and Chair of Ophthalmology at UT Southwestern, and Sanjay Chandrasekaran, MD, of UT Southwestern's Division of Hematology and Oncology, Eye Believe offered in-person and virtual participation for patients and caregivers from diagnosis through survivorship and metastatic disease.

A highlight of the weekend was a tour of the Harbour Lab, where attendees met the scientists studying ocular melanoma.

More on TelAve News

• RAS AP Consulting Issues National Compliance Alert and Launches Q4 2026 AP Readiness Program Ahead of IRS FIRE → IRIS Cutover
• Claude Zdanow named Managing Director in Miami, Florida
• Pregis Launches Sharp InfinX: On-Demand Rightsized Mailing System Delivering a Precision-Sized Mailer for Every Order
• netElastic Announces vBNG And CGNAT 2.0 General Availability
• Evergreen Surety Launches Telecommunications Surety Bonds Page as Broadband and 5G Buildout Expands Obligee Requirements

"This was an amazing experience for all of us. The scientists were equally overjoyed to see and chat with us. It was like putting the puzzle all together," said H. McMenamin.

Attendees also joined a HEPZATO tour and educational demonstration led by Dr. Chandrasekaran and Adrienne Shannon, MD, connecting discussions of liver-directed treatment for metastatic uveal melanoma with the clinical setting.

The medical program covered surveillance testing, biomarkers, adjuvant therapy, treatment sequencing, liver-directed therapies, emerging immunotherapy and targeted therapies, and symptom management after eye treatment. Patient and caregiver sessions addressed mental health, caregiver support, insurance, advocacy, and financial assistance, alongside patient roundtables and an INSIGHT Registry workshop.

"Eye Believe brings patients and caregivers into the conversation with the physicians and researchers working to improve their care," said Melody Burchett, Founder and President of A Cure In Sight. "The Harbour Lab tour and HEPZATO demonstration made those connections especially meaningful. We are grateful to UT Southwestern, our speakers, and our sponsors for helping us create a place where families can learn, ask questions, and find support."

More on TelAve News

• Postmortem Pathology Highlights Private Autopsy Options for Las Vegas Families During Summer Months
• Postmortem Pathology Offers Sacramento Families Independent Answers on a Short Timeline
• NEW Three Fully Furnished Single-Family Model Homes at Heritage at South Brunswick
• After 35 Years, Christian Radio Host Marina Maria Publishes the Novel She Never Forgot
• Freight Broker 911 CEO and President Milton Collier Is Rebuilding the Path Into Freight Brokerage

Featured speakers represented UT Southwestern Medical Center, Bascom Palmer Eye Institute, Princess Margaret Cancer Centre, Memorial Sloan Kettering Cancer Center, Sylvester Comprehensive Cancer Center, Northwestern University's Lurie Cancer Center, Keck School of Medicine of USC, Triage Cancer, Natera, and Oncobit, along with patient speaker Sophie Cantu and mental health professionals.

The 2026 Eye Believe Survivorship Seminar was supported by presenting sponsor Castle Biosciences, along with sponsors Immunocore, Delcath Systems, Aura Biosciences, IDEAYA Biosciences, TrilliumBio, and Novelwise.

Looking ahead, the 2027 Eye Believe Survivorship Seminar will be held with Dr. Carvajal and Dr. Materin at Northwell in Manhattan, New York. Additional details will be announced by A Cure In Sight. https://acureinsight.org/